000 01845cam  2200373zi 4500
0019.875874
003CaOODSP
00520221107164548
006m     o  d f      
007cr |||||||||||
008190704t20192019onc    |ob   f00| 0 eng d
020 |a9780660317496
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-284/2019E-PDF
24500|aManagement of applications and performance for drug establishment licences (GUI-0127).
24617|aGUI-0127 : |bmanagement of applications and performance for drug establishment licences
264 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2019.
264 4|c©2019
300 |a1 online resource (34 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Gestion des demandes et du rendement en matière de licences d’établissement de produits pharmaceutiques (GUI-0127).
500 |a"Date issued: November 27, 2019."
500 |a"Date implemented: April 1, 2020."
500 |aIssued also in HTML format.
504 |aIncludes bibliographical references (pages 29-31).
650 0|aPharmaceutical industry|xLicenses|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tGestion des demandes et du rendement en matière de licences d’établissement de produits pharmaceutiques.|w(CaOODSP)9.875873
85640|qPDF|s589 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H164-284-2019-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/management-applications-performance-drug-establishment-licences-0127/document.html